Electronic frailty index

There are 134 papers on electronic frailty index in aging research: 3 trials and 109 observational studies in people, 15 reviews. The newest story, Oct 4, 2026: “Electronic frailty index predicts CAR-T outcomes in older adults”.

Biomarker

134 papers study it28 more mention it114 findings

9 new papers in 30 daysSee all 162 papers on electronic frailty index

“One-year adjusted HR for mortality was 1.92 (95% CI 1.81-2.04) for mild frailty, 3.10 (95% CI 2.91-3.31) for moderate frailty and 4.52 (95% CI 4.16-4.91) for severe frailty.”
Development and validation of an electronic frailty index using routine primary care electronic health record dataAge and ageing2016doi:10.1093/ageing/afw039
  • Human trial3
  • Humans109
  • In silico3

Interventions

1

Anticholinergic agents

no changein humans1

1 study
  1. Anticholinergic agents were not clearly linked with electronic frailty index in humans (compared with β3-agonist use in overactive bladder).

    “Median eFI did not differ significantly between the groups during 5 years of follow-up.”

    Humanscompared with β3-agonist use in overactive bladder5 yearsfemales

    Anticholinergics link to higher dementia risk in older women

    International journal of urology : official journal of the Japanese Urological Association

More on Anticholinergic agents

Effects

13

Length of stay

upin humans1no changein humans1

2 studies
  1. Electronic frailty index is linked with higher length of stay in humans (hospitalized COVID-19 patients, controlling for age and sex) (β = 2.00, 95% CI 1.65-2.34).

    “and a longer length of stay (β-coefficient = 2.00; 1.65-2.34)”

    Humanshospitalized COVID-19 patients, controlling for age and sex10% incrementn = 3,980

    Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study

    Gerontology

  2. Electronic frailty index was not clearly linked with length of stay in humans (open revascularization for peripheral vascular disease).

    “There were no statistically significant differences in procedure type, LOS, or 30-day readmissions based on eFI.”

    Humansopen revascularization for peripheral vascular disease31% femalesn = 295

    Automated Electronic Frailty Index is Associated with Non-home Discharge in Patients Undergoing Open Revascularization for Peripheral Vascular Disease

    The American surgeon

Days alive and out of hospital in the first 30 days

downin humans1

1 study
  1. Electronic frailty index is linked with lower days alive and out of hospital in the first 30 days in older adults receiving CAR-T therapy (β= -3.79, p<0.01).

    “and fewer DAOH (β= -2.37, p = 0.03; β= -3.79, p<0.01).”

    Humansin older adults receiving CAR-T therapyn = 260

    Electronic frailty index predicts CAR-T outcomes in older adults

    Blood advances

Event-free survival

downin humans1HR 2.02

1 study
  1. Electronic frailty index is linked with lower event-free survival in older adults receiving CAR-T therapy (HR=2.02, p<0.01).

    “very frail patients had significantly worse OS (HR=1.64, p<0.05) and EFS (HR=2.02, p<0.01).”

    Humansin older adults receiving CAR-T therapyn = 260

    Electronic frailty index predicts CAR-T outcomes in older adults

    Blood advances

Overall survival

downin humans1HR 1.64

1 study
  1. Electronic frailty index is linked with lower overall survival in older adults receiving CAR-T therapy (HR=1.64, p<0.05).

    “very frail patients had significantly worse OS (HR=1.64, p<0.05)”

    Humansin older adults receiving CAR-T therapyn = 260

    Electronic frailty index predicts CAR-T outcomes in older adults

    Blood advances

Risk prediction discrimination

upin humans1

1 study
  1. Electronic frailty index is linked with better risk prediction discrimination in humans (Compared with Hospital Frailty Risk Score and Charlson Comorbidity Index).

    “Across all outcomes, the eFI showed greater model discrimination than HFRS and CCI.”

    HumansCompared with Hospital Frailty Risk Score and Charlson Comorbidity Indexn = 193,629

    A next-generation electronic frailty index leveraging deep learning on unstructured health records extends risk prediction across the full frailty spectrum

    medRxivPreprint

Model performance

upin humans1

1 study
  1. Electronic frailty index is linked with better model performance in humans (type 2 diabetes) (standard model vs. EFI; 0.616 vs. 0.631 and 0.776 vs. 0.778).

    “Incorporating eFI may improve model performance for both mortality and admission outcomes”

    Humanstype 2 diabetes

    The use of the electronic frailty index to optimise HbA1c targets in older individuals with type 2 diabetes

    Age and ageing

Urinary incontinence

no changein humans1

1 study
  1. Electronic frailty index was not clearly linked with urinary incontinence in humans (seeking treatment for UI) (r = 0.05, P = 0.74).

    “The eFI did not correlate with UI severity ([r] = 0.05, P = 0.74).”

    Humansseeking treatment for UIfemales

    Clinical Tools to Diagnose Frailty in Women With Geriatric Urinary Incontinence

    Urogynecology (Philadelphia, Pa.)

More on Urinary incontinence

Chair stand pace

no changein humans1

1 study
  1. Electronic frailty index was not clearly linked with chair stand pace in humans (seeking treatment for UI).

    “and did not correlate with chair stand pace.”

    Humansseeking treatment for UIfemales

    Clinical Tools to Diagnose Frailty in Women With Geriatric Urinary Incontinence

    Urogynecology (Philadelphia, Pa.)

Physical function

downin humans1

1 study
  1. Electronic frailty index is linked with worse physical function in humans (metastatic non-small-cell lung cancer on immunotherapy) (mean 83.9 fit vs 74.8 pre-frail vs 60.0 frail, P = .04).

    “Pre-frail and frail patients had significantly lower physical function scores (mean 83.9 fit vs 74.8 pre-frail vs 60.0 frail, P = .04)”

    Humansmetastatic non-small-cell lung cancer on immunotherapy60% womensn = 60

    The Association Between an Electronic Health Record (EHR)-Embedded Frailty Index and Patient-Reported Outcomes Among Patients with Metastatic Non-Small-Cell Lung Cancer on Immunotherapy: A Brief Report

    The American journal of hospice & palliative care

Chemotherapy cycles received

no changein humans1

1 study
  1. Electronic frailty index was not clearly linked with chemotherapy cycles received in humans (acute myeloid leukemia with less-intensive therapy and survival ≥6 months) (p = 0.97).

    “For those with less-intensive therapy who lived ≥6 months, eFI category was not associated with the number of chemotherapy cycles received (p = 0.97).”

    Humansacute myeloid leukemia with less-intensive therapy and survival ≥6 months

    Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia

    Journal of geriatric oncology

All 13

Associations

63

Mortality

upin humans21HR 1.29–7.31

21 studies
  1. Electronic frailty index is associated with mortality in humans (Pre-frail HR 1.7 (95% CI 1.2–2.3); frail HR 2.0 (1.3–3.1); not calculable HR 2.6 (1.7–4.0), versus fit).

    “EHR-derived frailty was associated with hospitalization and survival”

    HumansNewly diagnosed lung, colorectal, or breast cancer treated with chemotherapy; adjusted comparisons with fit patientsn = 509

    Electronic health record embedded frailty index and outcomes among older adults receiving cancer chemotherapy

    Journal of the National Cancer Institute

  2. Electronic frailty index is linked with a higher risk of mortality in older adults with atrial fibrillation (HR 2.10, 95% CI 1.72–2.57).

    “a 110% higher risk of all-cause mortality (HR 2.10, 95% CI 1.72–2.57; P < 0.001)”

    Humansin older adults with atrial fibrillation

    Cumulative Frailty Burden and Cardiovascular Outcomes in Atrial Fibrillation: Retrospective Analysis of UK Biobank

    Research SquarePreprint

  3. Electronic frailty index predicts mortality in humans (external validation) (C-statistic 0.83).

    “average C-statistic 0.83 (0.82 to 0.83)”

    Humansexternal validation

    Development and evaluation of the electronic frailty index+ (eFI+) tool for older people: prognostic prediction modelling with integrated decision curve and health economic analysis

    Health technology assessment (Winchester, England)

  4. Electronic frailty index is associated with mortality in humans (Severe frailty compared with non-frail) (HR 7.31, 95% CI 6.83–7.83).

    “severe frailty was associated with higher risks of mortality (hazard ratio [HR] 7·31, 95% confidence interval [CI] 6·83–7·83)”

    HumansSevere frailty compared with non-frailn = 193,629

    A next-generation electronic frailty index leveraging deep learning on unstructured health records extends risk prediction across the full frailty spectrum

    medRxivPreprint

  5. Electronic frailty index is associated with mortality in humans (Per 10% higher baseline frailty; adjusted for socioeconomic-related covariates) (HR 1.44 (95% CI 1.38–1.51) per 10% higher baseline frailty; before socioeconomic adjustment: HR 2.00 (1.93–2.07)).

    “although the magnitude of this association decreased when adjusting for socioeconomic-related covariates (HR (95% CI)=1.44 (1.38-1.51)).”

    HumansPer 10% higher baseline frailty; adjusted for socioeconomic-related covariatesFollow-up ≤10.2 yearsn = 208,982

    Health record frailty score linked to death risk in UK adults

    The journals of gerontology. Series A, Biological sciences and medical sciences

  6. Electronic frailty index predicts mortality in humans (aneurysmal subarachnoid hemorrhage) (aOR: 1.23, 95% CI: 1.00-1.49).

    “rebleeding (aOR: 5.93, 95% CI: 2.12–16.71), age (aOR: 1.10, 95% CI: 1.03–1.18), cerebrospinal fluid (CSF) diversion requirement (aOR: 3.11, 95% CI: 1.27–7.84) and the EFI (aOR: 1.23, 95% CI: 1.00-1.49)”

    Humansaneurysmal subarachnoid hemorrhagethree-monthn = 248

    Outcome predictors in older adults (≥ 65 years) with aneurysmal subarachnoid haemorrhage

    Neurosurgical review

  7. Electronic frailty index predicts mortality in humans (colorectal cancer treated with chemotherapy, severely frail, ≥70 y.o. vs <70 y.o) (OR 2.04 (95% CI 1.58-2.64)).

    “The risk of dying within 30 days of chemotherapy in severely frail patients with colorectal cancer ≥70 y.o. was twice that of the <70 y.o. (OR 2.04 -95% CI 1.58-2.64”

    Humanscolorectal cancer treated with chemotherapy, severely frail, ≥70 y.o. vs <70 y.o30 days

    The utility of electronic frailty index in cancer patients undergoing chemotherapy

    British journal of cancer

  8. Electronic frailty index predicts mortality in humans (post-operative older adults with eFI > 0.21) (HR 2.86, 1.84-4.44).

    “Post-operative frail (eFI>0.21) older adults experienced an elevated hazard of six-month mortality (HR 2.86, 1.84-4.44)”

    Humanspost-operative older adults with eFI > 0.216 months

    Gerontologizing the Learning Health System – The Electronic Frailty Index as a Passive Digital Marker for Frailty

    GSA 2025 abstract

  9. Electronic frailty index predicts mortality in humans (mild frailty) (HR 3.15, 95% CI 2.80-3.55).

    “age-sex adjusted 1-year mortality HRs were 3·15 (2·80-3·55) in younger adults with mild frailty”

    Humansmild frailty

    Applicability of the electronic frailty index in younger and older adults in England: a population-based cohort study

    The lancet. Healthy longevity

  10. Electronic frailty index predicts mortality in humans (aHR 1.77, 3.31, 6.65 (p < 0.005)).

    “adjusted hazard ratios of mortality of the mild, moderate and severe frail group were 1.77, 3.31 and 6.65 respectively and they were all statistically higher than the fit group. (p < 0.005)”

    Humans

    Developing an Electronic Frailty Index (eFI) and a biological age trajectory with a cohort of over one million older adults in Hong Kong

    The Journal of frailty & aging

All 22

Hospitalization

upin humans5HR 3.23–4.73

5 studies
  1. Electronic frailty index is associated with hospitalization in humans (Newly diagnosed lung, colorectal, or breast cancer treated with chemotherapy) (24% fit, 42% pre-frail, 62% frail, 50% non-calculable).

    “Six-month hospitalization increased with frailty: 24% (fit), 42% (pre-frail), 62% (frail), and 50% (non-calculable) (P<.0001).”

    HumansNewly diagnosed lung, colorectal, or breast cancer treated with chemotherapy6 monthsn = 509

    Electronic health record embedded frailty index and outcomes among older adults receiving cancer chemotherapy

    Journal of the National Cancer Institute

  2. Electronic frailty index predicts hospitalization in humans (solid tumors undergoing chemotherapy) (HR 3.23, 2.23-4.69).

    “Frail older adults with solid tumors undergoing chemotherapy experienced greater hazard of hospitalization (HR 3.23, 2.23-4.69)”

    Humanssolid tumors undergoing chemotherapy

    Gerontologizing the Learning Health System – The Electronic Frailty Index as a Passive Digital Marker for Frailty

    GSA 2025 abstract

  3. Electronic frailty index predicts hospitalization in humans (+62% (prefrail) and +137% (frail)).

    “individuals categorized as prefrail and frail had higher (62% and 137% respectively) risk of hospitalization compared to the robust group.”

    Humans

    Development and validation of a generalizable electronic frailty index: a prospective study in China

    BMC public health

  4. Electronic frailty index predicts hospitalization in humans (ED presentation) (OR 3.55, P < 0.0001).

    “adjusted odds ratios (OR) for hospitalization, in-hospital mortality, ICU admission, and ED readmission rose to 3.55, 14.15, 4.70, and 2.22, respectively (P < 0.0001)”

    HumansED presentationn = 21,537

    Enhancing emergency care for older persons: the role and impact of the electronic Frailty Index

    GeroScience

  5. Electronic frailty index predicts hospitalization in humans (severe frailty vs fit) (HR 4.73, 95% CI 4.43-5.06).

    “Corresponding estimates for hospitalisation were 1.93 (95% CI 1.86-2.01), 3.04 (95% CI 2.90-3.19) and 4.73 (95% CI 4.43-5.06)”

    Humanssevere frailty vs fit1 year

    Development and validation of an electronic frailty index using routine primary care electronic health record data

    Age and ageing

In-hospital mortality

upin humans5OR 1.65–19.97

5 studies
  1. Electronic frailty index is associated with in-hospital mortality in humans (Adjusted OR 3.69, 95% CI 2.45–5.55).

    “those in the frail group had significantly higher adjusted risks of in-hospital mortality (OR: 3.69, 95% CI: 2.45-5.55)”

    HumansHospitalized Chinese patients with gastrointestinal bleeding; eFI ≥0.27 versus eFI <0.27; adjusted associationduring hospitalizationn = 1,424

    The Electronic Frailty Index is Associated With In-hospital Mortality and Unfavorable Prognosis in Hospitalized Elderly Chinese Patients With Gastrointestinal Bleeding

    Journal of clinical gastroenterology

  2. Electronic frailty index predicts in-hospital mortality in humans (ED presentation) (OR 14.15, P < 0.0001).

    “adjusted odds ratios (OR) for hospitalization, in-hospital mortality, ICU admission, and ED readmission rose to 3.55, 14.15, 4.70, and 2.22, respectively (P < 0.0001)”

    HumansED presentationn = 21,537

    Enhancing emergency care for older persons: the role and impact of the electronic Frailty Index

    GeroScience

  3. Electronic frailty index is linked with a higher risk of in-hospital mortality in humans (hospitalized COVID-19 patients, controlling for age and sex) (OR 2.95, 95% CI 2.42-3.62).

    “a 10% increment in the eFI was significantly associated with higher risks of in-hospital mortality (odds ratio = 2.95; 95% confidence interval = 2.42-3.62)”

    Humanshospitalized COVID-19 patients, controlling for age and sex10% incrementn = 3,980

    Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study

    Gerontology

  4. Electronic frailty index is linked with a higher risk of in-hospital mortality in humans (OR 1.65 (95% CI 1.54-1.78) per 0.03 increment).

    “A 0.03 increment in the eFI was associated with higher risks of in-hospital (odds ratio: 1.65; 95% confidence interval: 1.54-1.78)”

    Humans0.03 increment

    Development of an Electronic Frailty Index for Hospitalized Older Adults in Sweden

    The journals of gerontology. Series A, Biological sciences and medical sciences

  5. Electronic frailty index is associated with in-hospital mortality in humans (inpatients with eFI≥0.15; adjusted for age, sex, and operation) (OR = 19.97).

    “an eFI≥0.15 showed an independent association with long hospital stay (odds ratio [OR] = 2.889, P < 0.001) and death in hospital (OR = 19.97, P < 0.001).”

    Humansinpatients with eFI≥0.15; adjusted for age, sex, and operation

    Development and Validation of an Electronic Frailty Index Using Routine Electronic Health Records: An Observational Study From a General Hospital in China

    Frontiers in medicine

30-day mortality

upin humans3HR 1.43–2.39

3 studies
  1. Electronic frailty index is linked with a higher risk of 30-day mortality in humans (hospitalized COVID-19 patients, controlling for age and sex) (HR 2.39, 95% CI 2.08-2.74).

    “30-day mortality (hazard ratio [HR] = 2.39; 2.08-2.74)”

    Humanshospitalized COVID-19 patients, controlling for age and sex10% increment30-dayn = 3,980

    Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study

    Gerontology

  2. Electronic frailty index is linked with a higher risk of 30-day mortality in humans (HR 1.43 (95% CI 1.38-1.48) per 0.03 increment).

    “30-day (hazard ratio [HR]: 1.43; 1.38-1.48), and 6-month mortality (HR: 1.34; 1.31-1.37) adjusted for age and sex.”

    Humans0.03 increment30 days

    Development of an Electronic Frailty Index for Hospitalized Older Adults in Sweden

    The journals of gerontology. Series A, Biological sciences and medical sciences

  3. Electronic frailty index predicts 30-day mortality in humans (patients admitted to nine public hospitals for heart failure) (AUC 0.90).

    “The area under the curve from a five-fold cross validation was 0.90 for gradient boosting and 0.87 and 0.86 for decision tree and logistic regression in predicting 30 day mortality.”

    Humanspatients admitted to nine public hospitals for heart failure30 dayn = 8,893

    Derivation of an electronic frailty index for predicting short-term mortality in heart failure: a machine learning approach

    ESC heart failure

6-month mortality

upin humans2HR 1.34–2.29

2 studies
  1. Electronic frailty index is linked with a higher risk of 6-month mortality in humans (hospitalized COVID-19 patients, controlling for age and sex) (HR 2.29, 95% CI 2.04-2.56).

    “6-month mortality (HR = 2.29; 2.04-2.56)”

    Humanshospitalized COVID-19 patients, controlling for age and sex10% increment6-monthn = 3,980

    Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study

    Gerontology

  2. Electronic frailty index is linked with a higher risk of 6-month mortality in humans (HR 1.34 (95% CI 1.31-1.37) per 0.03 increment).

    “and 6-month mortality (HR: 1.34; 1.31-1.37) adjusted for age and sex.”

    Humans0.03 increment6 months

    Development of an Electronic Frailty Index for Hospitalized Older Adults in Sweden

    The journals of gerontology. Series A, Biological sciences and medical sciences

Grade 3+ toxicity

upin humans1OR 4.84

1 study
  1. Electronic frailty index is linked with a higher risk of grade 3+ toxicity in older adults receiving CAR-T therapy (OR=4.84, p<0.01).

    “Both frail and very frail patients, respectively, had higher odds of grade 3+ toxicity (odds ratio [OR]=3.28, p<0.05; OR=4.84, p<0.01)”

    Humansin older adults receiving CAR-T therapyn = 260

    Electronic frailty index predicts CAR-T outcomes in older adults

    Blood advances

Major adverse cardiovascular events

upin humans1HR 1.92

1 study
  1. Electronic frailty index is linked with a higher risk of major adverse cardiovascular events in older adults with atrial fibrillation (HR 1.92, 95% CI 1.62–2.28).

    “highest quartile of cumulative frailty burden was associated with a 92% higher risk of MACEs (hazard ratio [HR] 1.92, 95% confidence interval [CI] 1.62–2.28; P < 0.001)”

    Humansin older adults with atrial fibrillation

    Cumulative Frailty Burden and Cardiovascular Outcomes in Atrial Fibrillation: Retrospective Analysis of UK Biobank

    Research SquarePreprint

More on Major adverse cardiovascular events

Care home admission

upin humans1

1 study
  1. Electronic frailty index predicts care home admission in humans (external validation) (C-statistic 0.86).

    “C-statistic of 0.86 (95% CI 0.86 to 0.86)”

    Humansexternal validation

    Development and evaluation of the electronic frailty index+ (eFI+) tool for older people: prognostic prediction modelling with integrated decision curve and health economic analysis

    Health technology assessment (Winchester, England)

Emergency department attendance/hospitalization with fall/fracture

upin humans1

1 study
  1. Electronic frailty index predicts emergency department attendance/hospitalization with fall/fracture in humans (external validation) (C-statistic 0.83).

    “C-statistic 0.83 (0.82 to 0.83)”

    Humansexternal validation

    Development and evaluation of the electronic frailty index+ (eFI+) tool for older people: prognostic prediction modelling with integrated decision curve and health economic analysis

    Health technology assessment (Winchester, England)

Home care package

upin humans1

1 study
  1. Electronic frailty index predicts home care package in humans (internal-external cross-validation) (C-statistic 0.81).

    “average C-statistic 0.81 (95% confidence interval 0.81 to 0.81)”

    Humansinternal-external cross-validation

    Development and evaluation of the electronic frailty index+ (eFI+) tool for older people: prognostic prediction modelling with integrated decision curve and health economic analysis

    Health technology assessment (Winchester, England)

All 63

Funding

6 grants since 2019

National Institute for Health Research£691KDepartment of Health, Australian GovernmentA$3.7MMedical Research Future FundA$3.4M

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 4Jan 2026: 7Feb 2026: 2Mar 2026: 3Apr 2026: 4May 2026: 4Jun 2026: 4Jul 2026: 3Aug 2026: 3Sep 2026: 2Oct 2026: 4Nov 2026: 848 papers in 12 months
The Lancet Digital Health

Health-record aging measure linked to disease and death

An aging measure developed in 320,891 UK Biobank participants was linked to all 20 non-cancer diseases assessed in two UK datasets.An aging measure developed in 320,891 UK Biobank participants was linked to all 20 non-cancer diseases assessed in two UK datasets.

Cohort · 4,728,376 peopleBiomarkers
The Lancet Healthy Longevity

Stopping statins linked to more hospital stays in older adults

Stopping statins was linked to a hospitalization risk 37.6 per 1,000 patients higher at one year than continuing them.Stopping statins was linked to a hospitalization risk 37.6 per 1,000 patients higher at one year than continuing them.

Cohort studyPopulations

See all 162 papers on electronic frailty index